This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: High-frequency oscillations (HFOs) can be recorded in epileptic patients with clinical intracranial EEG. HFOs have been associated with seizure genesis because they occur in the seizure focus and during seizure onset. HFOs are also found interictally, partly co-occurring with epileptic spikes. We studied how HFOs are influenced by antiepileptic medication and seizure occurrence, to improve understanding of the pathophysiology and clinical meaning of HFOs.
Methods: Intracerebral depth EEG was partly sampled at 2,000 Hz in 42 patients with intractable focal epilepsy. Patients with five or more usable nights of recording were selected. A sample of slow-wave sleep from each night was analyzed, and HFOs (ripples: 80–250 Hz, fast ripples: 250–500 Hz) and spikes were identified on all artifact-free channels. The HFOs and spikes were compared before and after seizures with stable medication dose and during medication reduction with no intervening seizures.
Results: Twelve patients with five to eight nights were included. After seizures, there was an increase in spikes, whereas HFO rates remained the same. Medication reduction was followed by an increase in HFO rates and mean duration.
Conclusions: Contrary to spikes, high-frequency oscillations (HFOs) do not increase after seizures, but do so after medication reduction, similarly to seizures. This implies that spikes and HFOs have different pathophysiologic mechanisms and that HFOs are more tightly linked to seizures than spikes. HFOs seem to play an important role in seizure genesis and can be a useful clinical marker for disease activity.
AED = antiepileptic drug; CBZ = carbamazepine; CLOB = clobazam; FR = fast ripple; FR_isol = fast ripples without co-occurring spikes; FR_Sp = fast ripples with co-occurring spikes; GBP = gabapentin; HFO = high-frequency oscillation; Lai/s = left anterior inferior/superior electrode (porencephalic cyst); LEV = levetiracetam; LF/p/a = left frontal/posterior/anterior electrode; LOP = left frontal operculum electrode; Lpi/s = left posterior inferior/superior electrode; L/RA = left/right amygdale electrode; L/RC/a/s = left/right cingulate/anterior/superior electrode; L/RE = left/right epidural electrode; L/RH = left/right hippocampus electrode; L/ROF = left/right orbitofrontal electrode; L/RO/i/s = left/right occipital/infracalcine/supracalcine electrode; L/RP = left/right parahippocampus electrode; L/RS = left/right supramarginal gyrus electrode; LSMAa/p = left supplementary motor area anterior/posterior electrode; LT = left anteriotemporal electrode; LTG = lamotrigine; OXC = oxcarbamazepine; PRI = primidone; PTH = phenytoin; R = ripple; R_isol = ripples without co-occurring spikes; R_Sp = ripples with co-occurring spikes; SEEG = stereo-EEG; SEZ = one or more seizures; SOZ = seizure onset zone; Sp = spike; TPM = topiramate.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard